CIK 0001094038 · Non-accelerated filer<br>Smaller reporting company
Marker Therapeutics, Inc.
Sign in to watch- Ticker
- MRKR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880277072
- Phone
- (713) 400-6400
- Business address
- 2450 HOLCOMBE BLVD, TMC PARTNERS OFFICE 1.311, HOUSTON, TX, 77021
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP, EDUVERSE COM
- 8-K Event Regulation FD disclosure
- 10-Q Report Quarterly Report
- NT 10-Q Other NT 10-Q
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 8-K Event Regulation FD disclosure
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- RW Other RW
- 10-Q Report Quarterly Report
- CORRESP Other Correspondence Between Filers and SEC Staff
- NT 10-Q Other NT 10-Q
- UPLOAD Other SEC-generated Letter
- 10-K Report Annual Report
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Restatement
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 32 of 46 · 904 filings